Neuro-Oncology Clinical Research
The Center for Neuro-Oncology participates in, and develops, numerous research studies and clinical trials. The goal is to help provide greater understanding, develop new methods to detect and diagnose those diseases, and focus on innovative treatments that are not broadly available to patients.
Clinical trials offer patients some of the very latest in care while giving physicians and researchers the opportunity to study the safety and effectiveness of new treatments. Participation is voluntary.
Our experienced neuro-oncology team, carefully review study criteria, potential benefits, risks, and other considerations with eligible patients for enrollment into a clinical study. Once enrolled, our clinical research staff carefully monitors patients throughout the research trial and is available to answer questions.
To learn more about our ongoing trials available at the Center for Neuro-Oncology, please contact our nurse at 877-601-6282.
Testing the Use of the Immunotherapy Drugs, Ipilimumab and Nivolumab, Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Study Information: NCT04396860
Sponsor: National Cancer Institute (NCI)
Principal Investigator: Neel Gandhi, MD
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024
A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioblastoma With Elevated Mutational Burden
Study Information: NCT04145115
Sponsor: National Cancer Institute (NCI)
Principal Investigator: Neel Gandhi, MD
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024
3D-PREDICT REGISTRY: 3D Prediction of patient-specific response using ex vivo interrogation of live cells from tumors
Study Information: NCT03561207
Sponsor: KIYATEC, Inc.
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024
Observation or radiation therapy in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery
Study Information: NCT03180268
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024
Molecular and biochemical characterization of malignant and metastatic brain tumors
Study Information: NCT N/A
Sponsor: Capital Health System, Inc. in collaboration with Princeton University and Rutgers University
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024
Genomically-guided treatment trial in brain metastasis
Study Information: NCT03994796
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Dr. Neel Gandhi, Medical Oncologist
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024
Assessing quality of life in adult neuro-oncology patients after Cyberknife or WBRT (Whole Brain Radiation Therapy), a prospective registry
Study Information: NCT N/A
Sponsor: Capital Health System, Inc.
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024
The use of the ketogenic diet as an adjuvant to treatment of glioblastome multiforme
Study Information: NCT N/A
Sponsor: Capital Health System, Inc.
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Dr. Neena Shetty, Clinical Research Coordinator at [email protected] or 609-394-4024